Project Grant K99DA062785
- Federal Grant Award Summary The Medical University of South Carolina received a $1,039,420 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 1, 2025, with a completion date of February 28, 2030. This award supports research investigating the neuronal mechanisms underlying opioid and alcohol use disorders through advanced molecular and imaging techniques. The project will employ multiplexed dissection of...
- Federal Grant Award Summary The Medical University of South Carolina (MUSC) received a $415,250 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective July 1, 2025, through June 30, 2027. This award supports research investigating the role of cortical astroglia in heroin-seeking behavior using rodent models of heroin self-administration and cue-induced heroin seeking. The research focuses on understanding how...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Medical University of South Carolina a $1.36 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025, and concluding February 28, 2030. This research initiative examines how social functioning metrics change during opioid use disorder (OUD) treatment and their association with positive treatment outcomes. The study will assess 100 patient-concerned...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Medical University of South Carolina a Project Grant of $139,851 under the Drug Use and Addiction Research Programs (CFDA 93.279) with an award date of October 10, 2025, and a completion date of April 30, 2028. This research initiative investigates the therapeutic potential of psilocybin in treating stress-cued heroin reinstatement in opioid use disorder (OUD) patients with comorbid post-traumatic...
- Federal Grant Award Summary American University received a $476,496 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded on August 15, 2025, with completion targeted for July 31, 2028. The award funds research investigating opioid signaling mechanisms in reward-guided decision-making within the rat prefrontal cortex, specifically the prelimbic area. The research integrates intra-cortical pharmacology,...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of North Carolina at Chapel Hill $206,955 under the Drug Use and Addiction Research Programs (CFDA 93.279) for a project period from June 15, 2025, through May 31, 2027. This Project Grant funds research investigating how learned negative affective states impact large-scale brain network activity, with specific focus on understanding the neural mechanisms underlying depression and substance use...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $182,249 Project Grant to The Medical University of South Carolina on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support research through June 30, 2029. The award funds the implementation and evaluation of EMPWR (Empowering Pregnant Women Receiving Medications for Opioid Use Disorder), a digitally enhanced clinical intervention designed to improve buprenorphine...
- Project Grant Award Summary The University of California, San Diego received a $158,246 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period of July 1, 2025 through June 30, 2027. The award funds a developmental research study examining the co-occurrence of posttraumatic stress disorder (PTSD) and substance use disorder (SUD) across childhood through adulthood. The primary deliverables include...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a $585,975 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to support basic and translational research on long non-coding RNAs (lncRNAs) in opioid use disorder (OUD) with consideration of HIV co-infection. The award, effective July 15, 2025 through March 31, 2030, funds discovery and functional characterization of lncRNAs at...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Alabama at Birmingham $1,351,034 under the Drug Use and Addiction Research Programs (CFDA 93.279) on April 15, 2025, for a project period extending through February 28, 2030. This Project Grant supports research investigating the mechanisms of operant reward seeking in prefrontal somatostatin-expressing interneurons, with particular focus on understanding how gamma-aminobutyric acid (GABA)...
The University of South Carolina received a $192,149 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded February 1, 2026, with completion targeted for January 31, 2028. This research initiative investigates noradrenergic mechanisms underlying stress-induced opioid reinstatement, addressing the neurobiological pathways through which traumatic stress and comorbid neuropsychiatric conditions—including anxiety, depression, and post-traumatic stress disorder—contribute to opioid use disorder initiation. The project focuses on elucidating circuit-level mechanisms of stress-related norepinephrine (NE) release within the prelimbic cortex of the medial prefrontal cortex and the role of these noradrenergic projections in oral oxycodone-seeking behaviors. The grant supports advanced translational research employing cutting-edge neuroscience techniques including chemogenetics, in vivo electrophysiology, and fiber photometry with GRAB (G-protein-coupled receptor activation-based) sensors to monitor neuronal activity and transmitter release across stress-responsive neural circuits. The research comprises multiple experimental aims designed to establish whether stress-evoked increases in neuroimmune activity within the locus coeruleus initiate downstream noradrenergic release that mediates stress-induced drug-seeking behavior. Findings from this project are expected to contribute to understanding the biological mechanisms linking trauma exposure to substance use disorder development and may inform prevention and treatment approaches for opioid addiction in populations with stress-related psychiatric comorbidities.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $192.1k | 1/21/26 |